Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The medicine may not absorb properly, so it may not work as well that day
When combined with diet and physical activity changes, brand-name Wegovy is approved by the Food and Drug Administration (FDA) for the following purposes: Weight loss in patients 12 years or older with obesity Body weight reduction in adults who are overweight and have at least one weight-related condition, such as high blood pressure, obstructive sleep apnea (OSA), or Type 2 diabetes Cardiovascular risk reduction in adults with heart disease and either obesity or overweight Treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis Wegovy is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist)
The employer channel is the real market
Other plans may cover weight-management medications such as Zepbound only when specific BMI and weight-related health-condition criteria are documented
